21.24  0.87 (4.27%)		08-14 16:00
Open: 20.45 High: 21.24 Volume: 23,635		Pre. Close: 20.37 Low: 20.17 Market Cap: 44(M)

Short term
Mid term
Targets	6-month :	24.91	1-year :	29.1
Resists	First :	21.33	Second :	24.91
Pivot price	20.07
Supports	First :	19.05	Second :	17.63
MAs	MA(5) :	20.47	MA(20) :	19.76
	MA(100) :	14.74	MA(250) :	12.01
MACD	MACD :	0.7	Signal :	0.8
%K %D	K(14,3) :	77.9	D(3) :	71
RSI	RSI(14): 63
52-week	High :	21.33	Low :	7.02

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ PILL ] has closed below upper band by 6.2%. Bollinger Bands are 26.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	21.27 - 21.36	21.36 - 21.45
Low:	19.97 - 20.05	20.05 - 20.14
Close:	21.09 - 21.25	21.25 - 21.41

PILL seeks to deliver investment results of 3x the daily performance of the S&P Pharmaceuticals Select Industry Index, a modified equal-weighted index that measures the performance of pharmaceutical companies, as defined by GICS, on the S&P Total Market Index. The fund uses derivatives and swaps to achieve its target exposure. As a levered product with daily resets, PILL is designed as a short-term trading tool and not a long-term investment vehicle. As a result, long-term returns could materially differ from those of the underlying index due to daily compounding. Prior to August 2, 2019, the fund aimed to provide 3x leveraged exposure to the Dynamic Pharmaceutical Intellidex Index. Effective February 27, 2026, the fund replaced the term Shares in its name with ETF.

Wed, 12 Aug 2026
Trading the Move, Not the Narrative: (PILL) Edition - Stock Traders Daily

Sat, 01 Aug 2026
(PILL) Volatility Zones as Tactical Triggers - Stock Traders Daily

Mon, 27 Jul 2026
Amneal Pharmaceuticals Inc (AMRX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Tue, 16 Jun 2026
Top Performing Leveraged/Inverse ETFs: 06/14/2026 - ETF Database

Wed, 27 May 2026
5 Small-cap Biotech ETFs to Watch in 2026 - Investing News Network

Thu, 23 Apr 2026
Equal-Weight ETFs Are the Play for Small-Cap Drug Development. Here's How to Position Now - 24/7 Wall St.

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Neutral
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Neutral
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Neutral
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Neutral
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Neutral
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Neutral

Exchange: AMEX
Sector: Financial Services
Industry: Asset Management
Shares Out	0 (M)
Shares Float	0 (M)
Held by Insiders	0 (%)
Held by Institutions	0 (%)
Shares Short	0 (K)
Shares Short P.Month	0 (K)

EPS	0
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	0 %
Return on Equity (ttm)	0 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	0
Qtrly Earnings Growth	0 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	0 (M)

PE Ratio	0
PEG Ratio	0
Price to Book value	0
Price to Sales	0
Price to Cash Flow	0

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.